View in EDS HTML Full Text PDF Full Text

Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study.

Saved in:
Bibliographic Details
Title: Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study.
Authors: Kao CM; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Division of Translational Medicine, Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.; Doctoral Program in Tissue Engineering and Regenerative Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan., Shih PC; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan., Chen DY; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.; Institute of Biomedical Science, Rong Hsing Research Center for Translational Medicine and Big Data Center, National Chung Hsing University, Taichung, Taiwan.; Rheumatology and Immunology Center, China Medical University Hospital, Taichung, Taiwan.; School of Medicine, China Medical University, Taichung, Taiwan., Chen HH; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, No. 1650, Sec. 4, Taiwan Boulevard, Taichung 40705, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.; Institute of Biomedical Science, Rong Hsing Research Center for Translational Medicine and Big Data Center, National Chung Hsing University, Taichung, Taiwan.; Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Department of Digital Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Source: Therapeutic advances in musculoskeletal disease [Ther Adv Musculoskelet Dis] 2026 Feb 23; Vol. 18, pp. 1759720X261423830. Date of Electronic Publication: 2026 Feb 23 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101517322 Publication Model: eCollection Cited Medium: Print ISSN: 1759-720X (Print) Linking ISSN: 1759720X NLM ISO Abbreviation: Ther Adv Musculoskelet Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41743537
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kao+CM%22">Kao CM</searchLink>; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Division of Translational Medicine, Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.; Doctoral Program in Tissue Engineering and Regenerative Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Shih+PC%22">Shih PC</searchLink>; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+DY%22">Chen DY</searchLink>; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.; Institute of Biomedical Science, Rong Hsing Research Center for Translational Medicine and Big Data Center, National Chung Hsing University, Taichung, Taiwan.; Rheumatology and Immunology Center, China Medical University Hospital, Taichung, Taiwan.; School of Medicine, China Medical University, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+HH%22">Chen HH</searchLink>; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, No. 1650, Sec. 4, Taiwan Boulevard, Taichung 40705, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.; Institute of Biomedical Science, Rong Hsing Research Center for Translational Medicine and Big Data Center, National Chung Hsing University, Taichung, Taiwan.; Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Department of Digital Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101517322%22">Therapeutic advances in musculoskeletal disease</searchLink> [Ther Adv Musculoskelet Dis] 2026 Feb 23; Vol. 18, pp. 1759720X261423830. <i>Date of Electronic Publication: </i>2026 Feb 23 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101517322 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1759-720X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221759720X%22">1759720X </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Musculoskelet Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41743537
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/1759720X261423830
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1759720X261423830
    Titles:
      – TitleFull: Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kao CM
      – PersonEntity:
          Name:
            NameFull: Shih PC
      – PersonEntity:
          Name:
            NameFull: Chen DY
      – PersonEntity:
          Name:
            NameFull: Chen HH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 02
              Text: 2026 Feb 23
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1759-720X
          Numbering:
            – Type: volume
              Value: 18
          Titles:
            – TitleFull: Therapeutic advances in musculoskeletal disease
              Type: main
ResultId 1